The Latest Breaking News from Peter Hotez

The inventors of Corbevax said it was cheap, easy to make, effective and safe. They hoped it could bring vaccine equity to countries that can't access costlier shots. Has it lived up to its promise?

Last week, the FDA authorized both Pfizer and Moderna's Omicron-specific jabs. Experts say to get them as soon as they are available to you.

If you have any fears of potential side effects, don’t hesitate to discuss them with medical personnel at your vaccination site or your own health care provider.

A 2005 study found that children under the age of eight are most likely to have severe outcomes from monkeypox, though experts say that’s far from definitive.

As students around the country start a new school year, providers say childhood immunization rates are too low, in some places, to prevent outbreaks of diseases like measles.

Sexual health clinics have been stretched so thin that many lack the staff to perform such basic duties as contacting and treating the partners of infected patients.

Clinics that treat sexually transmitted diseases — already struggling to contain an explosive increase in infections such as syphilis and gonorrhea — now find themselves on the front lines in the nation’s fight to control the rapidly growing monkeypox outbreak.

The new subvariant is responsible for a massive wave of new infections.

The fast-changing coronavirus has kicked off summer in the U.S. with lots of infections but relatively few deaths compared to its prior incarnations

Novavax hitched its wagon to the global coronavirus pandemic. Before most Americans truly grasped the scope of the danger, the small Maryland biotech startup had secured $1.6 billion in U.S. funding for its COVID-19 vaccine. Its moonshot goal: delivering 2 billion shots to the world by mid-2021.

The monkeypox outbreak theory is just the latest unproven claim to be promoted by the anti-vaxer